Library Search Results

“The Past, the Present, and the Future … Clinical Trials and the Contract Research Organisation (CRO)”
Helen Fovargue, Senior Legal Director, Quintiles, UK
A Glance at Some of the Challenges of the GC Role in Pharma
Galit Gonen, Senior Vice President & General Counsel for Teva Europe, Teva Pharmaceuticals, UK
A Patent Sea Change: The First Serving of Major Global Patent Law Changes Begins
Jason Garbell, Senior Patent Counsel, Novozymes AS, Denmark
A Path Through the Forest - The Role of Agency Guidance in Developing Regulatory Compliance Programs
Jack Sorokin, Deputy General Counsel (Retired), Beckman Coulter, Inc, USA
An Effective, Practical Approach to International Competition Law Compliance
Kent Bernard, Member, Bar of the Commonwealth of Pennsylvania, U.S.A., Kent Bernard, USA
Being Social: The FDA Pronounces on Interactive Promotional Media
Marianne Slivkova, Senior Corporate Counsel, Bristol Myers Squibb, USA
Canadian Risky Business: Why Fair and Predictable Patentable Utility is Critical to Investments and Innovation
Arvie Anderson, Assistant General Patent Counsel, Eli Lilly and Company, USA
Data Protection in the Pharmaceutical Industry: Concerns and Considerations
Leslie Restaino, General Counsel, Validus Pharmaceuticals, USA
Different Approaches to Pricing and Reimbursement of Innovative Pharmaceutical Products in Europe
Renato Dellamano, President, Value Vector, Italy
Digital Media in the Pharmaceutical Industry: Oportunities and Legal Challenges
Marc Bauer, Director & Senior Legal Counsel, Amgen, Switzerland
Doing Business in Brazil
Fatima Picôto, Legal Director Brazil, GlaxoSmithKline Brasil Ltda, Brazil
Enlightening The Jungle: The German Rules on Advertising Pharmaceuticals
Thorsten Witt, Corporate Counsel, Celesio, Germany
How Much Value is Your Company Losing? Implementing Effective Intellectual Property Management
Gunnar Wieboldt, Senior Corporate Counsel, Talecris Biotherapeutics, USA
Increased Evolution of Regulations Affecting the Pharmaceutical Law Practice
Jean Frydman, US General Counsel & Chief Compliance Officer, Ferring, USA
Left to Their Own Devices
Patrik Plöen, Legal Counsel, Q-Med, Sweden
Mediation as a Dispute Resolution Mechanism in High Tech Industry Collaborations: A Look at Pharma and Biotech
Jukka Muhonen, Director, Global Business Dev.& Alliance Management, Orion Corporation, Finland
More Than Words: Reflections of a General Counsel
Hassan B. Hassan, Associate General Counsel, GE Healthcare, UAE
Navigating the Headwaters of Intellectual Property Risk in the Pharmaceutical Industry
Simon Jenner, Chief Legal Officer, Acella Pharmaceuticals, LLC, USA
Pharmaceutical Advertising in Denmark - Where did Freedom of Expression go?
Nicolai Ellehuus, Corporate Counsel, Novo Nordisk As, Denmark
Nicolai Ellehuus, Corporate Counsel, Novo Nordisk As, Denmark
Pharmaceutical Ethic Codes: How to draft a Pharmaceutical Ethic Codes without inhibiting your business
Tri Junanto Wicaksono, Legal & GA Manager, PT. Amerta Indah Otsuka, Indonesia
Pharmaceutical Marketing and Transparency in Japan
Marianne Slivkova, Senior Corporate Counsel, Bristol-Myers Squibb Company, USA
Pharmaceutical Patent Protection in Turkey
Gaye Ramazanoglu, Intellectual Property Specialist, Sanovel, Turkey
R&D Based Pharmaceutical Companies Vs. Generic Companies: A False Dichotomy?
Sharon Reiche, Corporate Counsel, Intellectual Property Policy, Pfizer Inc, USA
Sharon Reiche, Corporate Counsel, Intellectual Property Policy, Pfizer Inc, USA
Self-Regulation of an Industry versus the Rule of Law
Howard Snoyman, Executive Legal Counsel, Solal Technologies (Pty) Ltd, South Africa
South Africa as a Destination of Choice for International Dispute Resolution
Howard Snoyman, Group Legal Executive, Ascendis Health Ltd, South Africa
Standing The Test of Time: Important Considerations in Long-Term Partnering Transactions
Gil M. Labrucherie, Vice President of Corporate Legal, Nektar Therapeutics, USA
Frank J. Curtis, Vice President-Law, Commercial & Regulatory, Nektar Therapeutics, USA
The Evolution of In-house Legal & IP Departments
Heather Harvey, Lead IP Operations, Syngenta International AG, Switzerland
Nicolas Lalyre, Head Patent Information, Syngenta International AG, Switzerland
Simon Reeves, Head of Trademarks, Syngenta International AG, Switzerland
Michael Kock, Head IP, Syngenta International AG, Switzerland
The Globalization of Clinical Trials - Challenges, Opportunities and a Path Forward
Cara Cuenot, lead counsel for the BioCorrection Research Unit, Pfizer Inc, USA
Marc Wilenzick, Assistant General Counsel, Pfizer Inc, USA
Justin McCarthy, Senior Vice President and Associate General Counsel, Pfizer Inc, USA
The Impact of the Fraud and Abuse Laws on Pharmaceutical Advertising and Marketing Compliance: A Manufacturer"s Perspective
Leslie Restaino, General Counsel, Validus Pharmaceuticals, USA
The new EFPIA Disclosure Code – Is the Need for Transparency Outweighing Data Privacy Compliance?
John Giannakakis, Regional Counsel Southern Europe , Novartis Hellas SACI, Greece
United States Jurisdiction Abroad
Fabiana Lacerca, Senior Vice President and Chief Compliance Officer, Elan Pharmaceuticals, USA
US and International Codes on Pharmaceutical Marketing Practices and Interaction with Healthcare Professionals - A Comparative Analysis and Outlook on Harmonization by FCPA Enforcement
Roy Birnbaum, Senior Legal Director, Human Health International, Merck & Co, USA